Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Erratum for The Meta-Analysis Group in Cancer, J Clin Oncol 22 (18) 3766-3775.

Journal of Clinical Oncology, Vol 23, No 6 (February 20), 2005: pp. 1337-1338
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.12.906

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Erratum

The September 15, 2004, article by The Meta-Analysis Group in Cancer entitled, "Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-Analysis" (J Clin Oncol 22:3766–3775, 2004) contained two errors.

The Results section of the abstract mistakenly states that the tumor response rates are 11% for FU-LV v 21% for FU alone. The correct response rates are 21% for FU-LV v 11% for FU alone.

In Table 1, several of the dosing regimens are given as "days 1–8, for 6 weeks". These dosing regimens should be "once weekly, for six weeks". The corrected Table is reprinted below in its entirety. The online version of the Table was corrected in departure from the print.


View this table:
[in this window]
[in a new window]
 
Table 1. Randomized Clinical Trials Comparing FU (± IFN-{alpha}) to FU-LV (± IFN-{alpha}) in Advanced Colorectal Cancer

 


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online